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Abstract 
A glycine to arginine substitution (GGG↔AGG substitutions) in codon 972   (Gly 972 Arg) is the common 
polymorphism of the IRS-1 gene. This polymorphism interfere with the interaction between IRS-1 and PI3-
kinase. It participate in the development of insulin resistance and diabetes by impairing the ability of insulin to 
activate the  IRS-1/PI3-kinase/Akt signaling pathway. The present study was designed to evaluate the association 
of insulin receptor substrate-1 gene G↔A (Gly 972 Arg) polymorphism with insulin resistance in type 2 diabetes 
mellitus in Iraqi population. To achieve this aim, 103 of type 2 diabetic patients and 57 apparently healthy 
control group were subjected to the study. The results of present study show that the heterozygous genotype (GA) 
of insulin receptor substrate-1 gene G↔A (Gly 972 Arg) SNP was significantly increased (OR=9.14, CI 95% 
1.13-75.53, P < 0.05) the risk of type 2 DM by nine folds with respect to those of wild genotype (GG). The allele 
frequencies of G and A were 92.93% and 7.07% for the insulin resistant type 2 diabetic patients group and 
99.04% and 0.96% for the control group respectively. Also, the results revealed that no significant differences in 
clinical characteristics between wild genotype (GG) and heterozygous genotype (GA). The study concluded that 
insulin receptor substrate-1 gene G↔A (Gly 972 Arg) SNP are associated and involved in the pathogenesis of  
insulin resistant type 2 diabetes mellitus. 
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1. Introduction 
Type 2 diabetes mellitus is a non autoimmune, heterogeneous and polygenic metabolic diseases characterized by 
hyperglycemia, resulting from impairment of insulin secretion and/or action (1). Insulin resistance, the reduction 
of insulin sensitivity by insulin responsive tissues lead to decrease the ability of insulin to inhibit the production 
of glucose by the liver and decrease peripheral glucose utilization. Consequently blood glucose level would be 
rise in insulin resistance and increase the secretion of insulin to overcome insulin resistance (2). 
Insulin promotes different metabolic effects by binding to the insulin receptor and stimulating its 
intrinsic tyrosine kinase. Tyrosine kinase phosphorylat tyrosine residues of a different proteins such as insulin 
receptor substrate (IRS) (3). Several genetic polymorphisms of IRS-1 gene and their effects on insulin action 
have been identified. A glycine to arginine substitution (GGG↔AGG substitutions) in codon 972 (Gly 972 Arg) 
is the common polymorphism of the IRS-1 gene (4).  In human, the IRS-1 gene is localized on chromosome 2. 
The IRS are essential for insulin action and therefore it important for the regulation of the hepatic glucose 
production and lipid metabolism. Any defect in this complex system leads to impairment in the insulin signaling 
pathway resulting in insulin resistance and type 2 diabetes (5, 6).  
 
1.1. Aims of the study         
The aim of this study to evaluate the prevalence and association of insulin receptor substrate-1 gene G↔A (Gly 
972 Arg) SNP in insulin resistant type 2 diabetic patient in Iraqi population. 
 
2. Materials and Methods 
2.1. Materials 
2.1.1. Subjects 
The study included type 2 diabetic patients and control group. All samples were collected from February 2013 
till May 2013. The work was carried out in the biochemistry department laboratory in College of 
Medicine/University of Kufa. The study was performed on 103 of type 2 diabetic patients and 57 apparently 
healthy control group. Any subject suffered from problems such as, renal dysfunction, heart diseases, 
hypertension, patient on insulin therapy and drug dependency such as glucocorticoid were excluded from the 
current study. 
2.1.2. Blood Sampling 
Five milliliters of blood was taken from all subjects by vein puncture in fasting status and the blood was divided 
into two parts, the first part include three milliliters of blood placed in plain tube for estimation of insulin, 
glucose, total cholesterol, HDL-cholesterol, TGs, VLDL-cholesterol and LDL-cholesterol concentrations. The 
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second part for gene analysis includes two milliliters of blood will be collected in EDTA containing tube. 
 
2.2. Methods 
Serum glucose, total cholesterol, triglycerides (TGs) and HDL-cholesterol concentration determined by 
spectrophotometric methods, while serum insulin concentration determined by enzyme linked immunosorbant 
assay (ELISA) method. Insulin resistance was evaluated by homeostatic model assessment (HOMA) method.  
Genotyping of IRS-1 gene G↔A (Gly 972 Arg) was carried out by polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP). The DNA extracted from frozen blood by genomic 
DNA mini kit (Geneaid) (7). The DNA was amplified by PCR. A 221 bp DNA fragment containing the 
polymorphic site G↔A (Gly 972 Arg) of IRS-1 gene was amplified by using specific primers (forward primer 
5'-GCA GCC TGG CAG GAG AG-3' and reverse primer 5'-CTC ACC TCC TCT GCA GC-3') (8). The PCR 
products were digested with BstOI (Bioneer /Korea). The wild genotype (GG) remains uncut (221 bp) whereas  
the homozygous genotype (AA) is digested into 190 and 31 bp fragments. The heterozygous genotype (GA) 
contained three bands sized 221, 190 and 31 bp. The restriction digestion products were analyzed on 3% agarose 
gel electrophoresis.   
 
2.3. Statistical Analysis     
The results of phenotypes data were expressed as mean ± SD. Student’s t-test was used for the evaluation of data. 
Genotype data expressed as odds ratio (OR), confidence interval (CI) 95%. Statistical analyses were performed 
with SPSS  (version 20). P-value less than 0.05 was considered to be statistically significant. 
 
3. Results 
Fasting glucose, insulin, HOMA and total cholesterol, TG, VLDL-cholesterol and LDL-cholesterol levels were 
found to be elevated significantly (p < 0.001) in type 2 diabetic patients when compared to those of the control 
group. However HDL-cholesterol was observed to be lowered significantly (p < 0.05) during comparable 
evaluation as shown in table 1. 
Results indicated that 92 (89%) out of 103 type 2 diabetic patients were insulin resistant when they 
were evaluated by the HOMA method. However 5 (9%) out of 57 healthy individuals were observed to be 
insulin resistant when they were analyzed similarly, hence these patients were excluded from the current 
investigation.  
The analysis of results indicated that the IRS-1 gene G↔A (Gly 972 Arg) SNP genotype frequencies of 
wild genotype (GG) and heterozygous genotype (GA) were 85.87% and 14.13% in the insulin resistant type 2 
diabetic patients and 98.08% and 1.92% in the control group respectively. The homozygous genotype (AA) were 
absent in insulin resistant type 2 diabetic patients and the control group. The heterozygous genotype (GA) was 
found to significantly increase (OR=9.14, CI 95% 1.13-75.53,      P < 0.05) the risk of type 2 DM by nine folds 
with respect to those of the wild genotype (GG) after adjustment for age, sex and BMI. No significant variations 
were obtained when the analysis was carried out without adjustment as shown in  table 2. The allele frequencies 
of G and A were 92.93% and 7.07% for the insulin resistant type 2 diabetic patients group and 99.04% and 
0.96% for the control group respectively as shown in table 3. Finally, the results of present study reveal that no 
significant differences in clinical characteristics (fasting glucose, insulin, HOMA, total-cholesterol, HDL-
cholesterol, TG, VLDL-cholesterol, LDL-cholesterol and BMI) between wild genotype (GG) and heterozygous 
genotype (GA). 
 
4. Discussion 
Whereas many different genes have been projected as diabetogenes, this study focused on the IRS-1 gene. IRS-1 
is the major substrate that contribute in insulin action in insulin sensitive tissues. Defects in IRS-1 which is main 
substrate tyrosine phosphorylation characterizes insulin resistance associated with diabetes (9). The IRS-1 is an 
endogenous substrate of the insulin receptor that play an essential role in the insulin signaling pathway and it 
expressed in insulin sensitive tissues. Subsequent to the binding of insulin to its receptor, the intrinsic tyrosine 
kinase activity of the insulin receptor β subunit is activated, thus catalyzing the phosphorylation of specific 
tyrosine residues on the IRS-1 protein (10).  
This phosphotyrosine residues on IRS proteins become good targets for the p85 subunit of PI3-kinase. 
The activated PI3-kinase activate Akt, it has multiple biological function of insulin including glucose transport, 
translocation of glucose transporter protein to the plasma membrane and glycogen synthesis (11, 12). The Gly 
972 Arg polymorphism is found close to the C-terminus of IRS-1 and it positioned between two potential 
tyrosine phosphorylation sites, this sites represent the binding sites for the p85 subunit of PI3-kinase (13). 
The Gly 972 Arg polymorphism did not change the expression level of IRS-1 or the degree of insulin 
stimulated tyrosine phosphorylation of  IRS-1, but the Arg 972 polymorphism interfere with the interaction 
between IRS-1 and PI3-kinase, may be by altering the tertiary structure of IRS-1 (14, 15). For this explanation, 
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the Arg 972  IRS-1 polymorphism may participate in the development of insulin resistance and diabetes by 
impairing the ability of insulin to activate the IRS-1/PI3-kinase/Akt signaling pathway, consequently leading to 
defects in glucose transport, glucose transporters translocation and glycogen synthesis. 
The current results are in consistence with the results of Laura et al. (16) and   Fulden et al. (17) studies 
in which the IRS-1 gene G↔A (Gly 972 Arg) SNP was found to be increased risk of type 2 DM. On the other 
hand it differed from those described by Kozarova et al. (18) and Baroudi et al. (19) who did not find an 
association between IRS-1 gene G↔A (Gly 972 Arg) SNP and type 2 DM.  
 
5. Conclusions 
Insulin receptor substrate-1 gene G↔A (Gly 972 Arg) SNP is associated and involved in the pathogenesis of 
insulin resistant type 2 diabetes mellitus in Iraqi population with a nine folds increase of the risk of the disease.   
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Table 1: Mean Fasting Serum Glucose, Insulin, HOMA, and Lipid Profile Concentration in Type 2 Diabetic 
Patients and the Control Group 
Parameter  Subjects Mean ± SD Range P-value 
Glucose (mmol/L) Control 4.83 ± 0.68 3.2-5.9 < 0.001 
patient 9.94 ± 2.95 7.1-20.2 
Insulin (µIU/mL) Control 8.24 ± 2.98 1.56-15.27  
< 0.001 patient 15.82 ± 7.79 5.47-44.36 
HOMA 
 
Control 1.80 ± 0.68 0.33 - 3.37  
< 0.001 patient 7.12  ± 4.29 2.16 - 28.45 
Total 
Cholesterol 
(mmol/L) 
Control 4.20 ± 0.72 2.66-5.39  
< 0.001 Patient 5.04 ± 0.92 3.81-6.91 
HDL 
Cholesterol 
(mmol/L) 
Control 1.04 ± 0.26 0.58-1.79  
< 0.05 Patient 0.96 ± 0.22 0.52-1.54 
Triglycerides 
(mmol/L) 
Control 1.25 ± 0.52 0.49-2.27  
< 0.001 Patient 2.05 ± 0.94 0.56-3.97 
VLDL 
Cholesterol 
(mmol/L) 
Control 0.56±0.23 0.22-1.02  
< 0.001 Patient 0.92 ± 0.42 0.25-1.78 
LDL 
Cholesterol 
(mmol/L) 
Control 2.59 ± 0.77 1.16-4.19  
< 0.001 Patient 3.15 ± 1.01 1.15-5.39 
 
Table 2: Genotypes Distribution of Insulin Receptor Substrate-1 Gene G↔A (Gly 972 Arg) SNP in Insulin 
Resistance Type 2 Diabetic Patients and the Control Group  
Genotype Type 2 DM Control Unadjusted OR 
(95% CI) 
P-value 
Adjusted OR 
(95% CI) 
P-value 
GG No. 79 51 Reference Reference 
% 85.87% 98.08% 
GA 
 
No. 13 1 8.39 (1.06-66.12) 
P < 0.05 
9.14 (1.13-75.53) 
P < 0.05 % 14.13% 1.92% 
AA No. 0 0 - - 
% - - 
Total No. 92 52 - - 
% 100% 100% 
 
Table 3:  Allele Frequency of Insulin Receptor Substrate-1 Gene G↔A (Gly 972 Arg) SNP in Insulin 
Resistance Type 2 Diabetic Patients and the Control Group  
Allele Type 2 DM Control OR (95% CI) P-value 
G Allele No. 171 103 Reference Reference 
% 92.93% 99.04% 
A Allele No. 13 1 7.83 
(1.00-60.74) 
 
< 0.05 % 7.07% 0.96% 
Total Allele No. 184 104 - - 
% 100% 100% 
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